Dr Reddys Laboratories (RDY) Total Current Liabilities (2009 - 2026)

Dr Reddys Laboratories has reported Total Current Liabilities for 18 years, with the latest figure at $1.7 billion in Q2 2026.

• On a quarterly basis, Total Current Liabilities changed 0.25% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 0.25% change from a year earlier, with the FY2026 full-year figure at $1.8 billion, up 17.03% from the prior year.
• Total Current Liabilities was $1.7 billion for Q2 2026 at Dr Reddys Laboratories, down from $1.8 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.8 billion in Q1 2026, with the low at $983.1 million in Q2 2023.
• Average Total Current Liabilities over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities retreated 16.51% in 2023, then jumped 51.59% in 2024.
• Over 5 years, Total Current Liabilities stood at $1.0 billion in 2022, then rose by 9.37% to $1.1 billion in 2023, then soared by 39.02% to $1.6 billion in 2024, then advanced by 13.76% to $1.8 billion in 2025, then dropped by 6.51% to $1.7 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.7 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.